Kilcoyne: Micrus will Acquire a Flow Diverter

John Kilcoyne, Micrus Endovascular CEO, dismissed aneurysm flow diversion as a niche opportunity applicable to a small subset of cerebral aneurysm and warned of future in-stent stenosis potential side effects.

However, Mr. Kilcoyne, confirmed that Micrus Endovascular is working on acquiring the technology and is currently working with Flexible Stenting Solutions to develop a laser-cut carbon coated nitinol aneurysm flow diverting device.

The remarks were made today, January 12, 2010 at Needham Growth Conference 12th Annual.

Read more...

Kilcoyne: Micrus will Acquire a Flow Diverter

John Kilcoyne, Micrus Endovascular CEO, dismissed aneurysm flow diversion as a niche opportunity applicable to a small subset of cerebral aneurysm and warned of future in-stent stenosis potential side effects.

However, Mr. Kilcoyne, confirmed that Micrus Endovascular is working on acquiring the technology and is currently working with Flexible Stenting Solutions to develop a laser-cut carbon coated nitinol aneurysm flow diverting device.

The remarks were made today, January 12, 2010 at Needham Growth Conference 12th Annual.

Read more...

Flexible Stenting Solutions

Flexible Stenting Solutions, a privately held medical device company focused on the development and commercialization of flexible stents built on a proprietary design platform, has entered into a lincensing and co-development agreement with Micrus Endovascular, in August 2009, to develop a carbon covered Nitinol laser-cut cerebral aneurys flow diverting device.

Flexible Stenting Solutions also develops third generation self-expanding stent designed for the harsh loading conditions present in the superficial femoral and popliteal arteries. the company received CE Mark authorization for both its FlexStent Femoropopliteal and Biliary Self Expanding (SE) Stent Systems in January 2009.

Flexible Stenting also received 510(k) clearance for its FlexStent Biliary Self Expanding Stent System in September 2009.

Read more...

Flexible Stenting Solutions

Flexible Stenting Solutions, a privately held medical device company focused on the development and commercialization of flexible stents built on a proprietary design platform, has entered into a lincensing and co-development agreement with Micrus Endovascular, in August 2009, to develop a carbon covered Nitinol laser-cut cerebral aneurys flow diverting device.

Flexible Stenting Solutions also develops third generation self-expanding stent designed for the harsh loading conditions present in the superficial femoral and popliteal arteries. the company received CE Mark authorization for both its FlexStent Femoropopliteal and Biliary Self Expanding (SE) Stent Systems in January 2009.

Flexible Stenting also received 510(k) clearance for its FlexStent Biliary Self Expanding Stent System in September 2009.

Read more...